L01XD07 padeliporfin
ATC group of level 5 – chemical substance · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 2 medicines in this group.
Active substance: Padeliporfin di-potassium – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XD07 padeliporfin 2 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Tookad 183 mg powder for solution for injection SPC | – |
| Tookad 366 mg powder for solution for injection SPC | – |
Other groups of the same level
- L01XD01 porfimer sodium 2 medicines
- L01XD03 methyl aminolevulinate 1 medicine
- L01XD04 aminolevulinic acid 4 medicines
- L01XD05 temoporfin 1 medicine
Other names of the ATC group
- Czech: L01XD07 Padeliporfin
- German: L01XD07 Padeliporfin
- Turkish: L01XD07 padeliporfin
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XD07
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
